Dr. Bousman is an Associate Professor in the Department of Medical Genetics at the University of Calgary, where he leads the Psychiatric Pharmacogenomics Laboratory. His program of research spans pharmacogenomic discovery and clinical implementation, with particular attention given to improving prescribing for mental health conditions across life stages. Dr. Bousman has published over 180 peer-reviewed papers and has received over $10 million in research support from Canadian, US, and Australian funding agencies. He is a member of the American College of of Neuropsychopharmacology, Clinical Pharmacogenetics Implementation Consortium (CPIC), Pharmacogene Variation (PharmVar) Consortium, Pharmacogenomics Global Research Network (PGRN), and the Standardized Laboratory Practices in Pharmacogenomics (STRIPE) Collaborative. He is also the founder and CEO of Sequence2Script Inc, a software company that assists genomic laboratories with translating pharmacogenomic information into clinical action.